Alzheimer ’s disease is the most common form of dementia.
The hereditary Alzheimer ’s disease (AD) Panel analyzes three genes associated with early-onset hereditary Alzheimer’s disease which is characterized by progressive memory loss, language disturbances, and psychiatric manifestations.
Individuals with a clinical diagnosis of early-onset AD, especially those with a strong family history of dementia, may benefit from diagnostic genetic testing. Identification of the molecular basis of disease in an affected individual may help to confirm the suspected diagnosis, provide anticipatory guidance, determine which relatives may be at risk, and/or promote enrollment in clinical trials.
Alzheimer’s disease is an irreversible, progressive brain disease. It is characterized by the development of amyloid plaques and neurofibrillary tangles; the loss of connections between nerve cells in the brain; and the death of these nerve cells.
There are two types of Alzheimer’s – early-onset and late-onset. Both types have a genetic component. component.